1. Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development
   Jennifer A. Kricker et al, 2021, Pharmacological Reviews CrossRef
2. Azithromycin Mitigates Cisplatin-Induced Lung Oxidative Stress, Inflammation and Necroptosis by Upregulating SIRT1, PPARγ, and Nrf2/HO-1 Signaling
   Emad H. M. Hassanein et al, 2022, Pharmaceuticals CrossRef
3. Natural Products Derived from Marine Sponges with Antitumor Potential against Lung Cancer: A Systematic Review
   Alba Ortigosa-Palomo et al, 2024, Marine Drugs CrossRef
4. A mini‐review on anticancer‐related properties of azithromycin and its potential activities in overcoming the challenges of glioblastoma
   Siti Nazihahasma Hassan et al, 2023, Fundamental & Clinical Pharmacology CrossRef
5. Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration
   Wener Li et al, 2022, Pharmaceuticals CrossRef
6. Azithromycin enhances the cytotoxicity of DNA‐damaging drugs via lysosomal membrane permeabilization in lung cancer cells
   Kazutoshi Toriyama et al, 2021, Cancer Science CrossRef
7. Regulated cell death (RCD) in cancer: key pathways and targeted therapies
   Fu Peng et al, 2022, Signal Transduction and Targeted Therapy CrossRef
8. Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
   Xin Jin et al, 2024, Acta Pharmaceutica Sinica B CrossRef
9. Azithromycin inhibits the intracellular persistence of Acinetobacter baumannii by inducing host cell autophagy in human bronchial epithelial cells
   Bangbi Weng et al, 2024, Microbial Pathogenesis CrossRef
10. In vitroanticancer effect of azithromycin targeting hypoxic lung cancer cells via the inhibition of mitophagy
    Kazutoshi Toriyama et al, 2023, Oncology Letters CrossRef
11. Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy
    Shutong Li et al, 2024, Immunological Reviews CrossRef
12. Induction of synergistic non‑apoptotic cell death by simultaneously targeting proteasomes with bortezomib and histone deacetylase 6 with ricolinostat in head and neck tumor cells
    Kazuhiro Hattori et al, 2021, Oncology Letters CrossRef
13. Anti-tumor activity of trimethoprim-sulfamethoxazole against melanoma skin cancer through triggering allergic reaction and promoting immunity
    Hee-Yun Kim et al, 2023, International Immunopharmacology CrossRef
14. Magnetic modulation of lysosomes for cancer therapy
    Yingze Li et al, 2024, WIREs Nanomedicine and Nanobiotechnology CrossRef